CATHIS simulators in medical technology
Use your resources and your time particularly effectively with the innovative CATHIS® Simulator
This applies to all processes from conception through research and development to clinical trials of the approval tests
After all, the manufacturers that fulfill the criterion of time to market particularly well have a clear strategic competitive advantage. High investments and the long development time to market maturity of a product as well as the risk of premature failure pose growing challenges for medical technology companies. Many new products and technical procedures are not FDA-approved because the clinical outcomes were not satisfactory, or in Europe EMA does not grant approval for other reasons. There is also a further risk in Germany: an approved new medical device or procedure can be denied by the statutory health insurance, which accounts for about 70 percent of all treatment costs, because of unconvincing profit in terms of cost-effectiveness.
- Support of the R & D process through simulation
- Practical testing with the help of simulation
- Increase the success of the market introduction with simulation
With high-quality products, the medical technology industry can make an important contribution to patient safety
Test your medical devices and sample them thoroughly in the field using our simulation
R & D process
Development teams in medical technology usually work without close proximity to the patient. Laboratory experiments on living or dead animals, however, only incompletely predict how vessels and tissues in humans react in everyday clinical practice. However, specialists in research and development do not need to decline realistic anatomies and patient cases. With its stationary and mobile devices, CATHI GmbH offers many possibilities to simulate the use of instruments even under special conditions. If required, certain anatomical situations can be custom programmed on the basis of real patients. This results in important advantages:
- Avoiding of animal experiments
- Costs reduction
- Time savings
- Higher product quality by usage of patient data
New instruments and procedures can be tested in a variety of cases using simulation, long before clinical trials or final field trials begin. This is an priceless advantage, especially as a valuable hands-on assessment of the application is possible at an early stage. It is no coincidence that the FDA and EMA guidelines require the use of simulation techniques in the development and testing of new products.
When introducing a product, physicians and key opinion leaders can be systematically informed through simulated demonstrations. In the same way, the medical staff of each team gets to know the new application better. Such a market entry will lead to a more intensive exchange between users and manufacturers about the product, which can not be overestimated, especially with regard to customer orientation and quality management.
Consistently reducing the number of treatment errors and protecting the patient from the risks of his treatment is a high priority in medical care. Patient safety is a key task in healthcare. It also must be guaranteed in view of staff shortages, increasing administrative requirements and increasing economic pressure in everyday clinical practice. The simulation of medical interventions is in itself a patient safety procedure.
Get in touch with us and tell us what you think about the planned assignment.